Nikolas Kesten

544 total citations
6 papers, 57 citations indexed

About

Nikolas Kesten is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nikolas Kesten has authored 6 papers receiving a total of 57 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nikolas Kesten's work include Protein Degradation and Inhibitors (2 papers), Genomics and Chromatin Dynamics (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). Nikolas Kesten is often cited by papers focused on Protein Degradation and Inhibitors (2 papers), Genomics and Chromatin Dynamics (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). Nikolas Kesten collaborates with scholars based in United States, Ireland and United Kingdom. Nikolas Kesten's co-authors include Henry W. Long, Len Taing, Myles Brown, Paloma Cejas, Alba Font‐Tello, Yingtian Xie, Ariel Feiglin, Anis Hamid, Leonie S. Young and Damir Varešlija and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Nature Protocols.

In The Last Decade

Nikolas Kesten

6 papers receiving 56 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nikolas Kesten United States	4	44	14	11	11	6	6	57
Aysegül Kaymak Türkiye	5	40 0.9×	6 0.4×	9 0.8×	8 0.7×	5 0.8×	8	60
James R. Hawley Canada	2	26 0.6×	11 0.8×	4 0.4×	11 1.0×	9 1.5×	2	35
Cyril Fournier France	6	32 0.7×	4 0.3×	8 0.7×	14 1.3×	9 1.5×	9	54
Zachary Weber United States	5	44 1.0×	12 0.9×	12 1.1×	15 1.4×	20 3.3×	10	78
Luca Pignata Italy	4	49 1.1×	11 0.8×	12 1.1×	16 1.5×	2 0.3×	9	72
Dagmar Hlávková Czechia	3	17 0.4×	21 1.5×	14 1.3×	8 0.7×	2 0.3×	5	43
Kristy Berry United States	4	47 1.1×	10 0.7×	21 1.9×	5 0.5×	2 0.3×	18	71
Ashir A. Borah United States	5	54 1.2×	15 1.1×	11 1.0×	9 0.8×	1 0.2×	6	66
Koro Nishikata Japan	4	39 0.9×	6 0.4×	4 0.4×	8 0.7×	5 0.8×	7	54
Qiheng Qian China	5	42 1.0×	6 0.4×	4 0.4×	15 1.4×	6 1.0×	10	66

Countries citing papers authored by Nikolas Kesten

Since Specialization

Citations

This map shows the geographic impact of Nikolas Kesten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikolas Kesten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikolas Kesten more than expected).

Fields of papers citing papers by Nikolas Kesten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikolas Kesten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikolas Kesten. The network helps show where Nikolas Kesten may publish in the future.

Co-authorship network of co-authors of Nikolas Kesten

This figure shows the co-authorship network connecting the top 25 collaborators of Nikolas Kesten. A scholar is included among the top collaborators of Nikolas Kesten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikolas Kesten. Nikolas Kesten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Alečković, Maša, Zheqi Li, Xintao Qiu, et al.. (2023). Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer. Molecular Cancer Therapeutics. 22(11). 1304–1318. 6 indexed citations

2.

Giannikou, Krinio, Elio Adib, Inga‐Marie Schaefer, et al.. (2022). Distinct oncogenic signatures in malignant PEComa and leiomyosarcoma identified by integrative RNA-seq and H3K27ac ChIP-seq analysis.. Journal of Clinical Oncology. 40(16_suppl). 11552–11552. 1 indexed citations

3.

Qiu, Xintao, Avery Feit, Ariel Feiglin, et al.. (2021). CoBRA: Containerized Bioinformatics Workflow for Reproducible ChIP/ATAC-Seq Analysis. Genomics Proteomics & Bioinformatics. 19(4). 652–661. 16 indexed citations

4.

Liu, Joyce F., Nikolas Kesten, Kin-Hoe Chow, et al.. (2021). Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient TP53 Mutant Uterine Carcinomas Is Linked to the Summation of LKB1–AKT–p53 Interactions. Cancers. 13(9). 2195–2195. 1 indexed citations

5.

Shah, Neel, Nikolas Kesten, Alba Font‐Tello, et al.. (2020). ERG-Mediated Coregulator Complex Formation Maintains Androgen Receptor Signaling in Prostate Cancer. Cancer Research. 80(21). 4612–4619. 11 indexed citations

6.

Font‐Tello, Alba, Nikolas Kesten, Yingtian Xie, et al.. (2020). FiTAc-seq: fixed-tissue ChIP-seq for H3K27ac profiling and super-enhancer analysis of FFPE tissues. Nature Protocols. 15(8). 2503–2518. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact